This case-based interactive module is based on a published clinical practice guideline titled: Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline.

The content can be viewed in either English or Spanish.

Upon completion of this activity, the participant should be able to:

1. Apply recent updates in the treatment of individuals with narcolepsy
2. Examine the quality and strength of the evidence supporting pharmacologic therapies in the management of narcolepsy
3. Recognize potential adverse effects of common medications used for the treatment of narcolepsy
4. Identify potential areas where additional research is needed to inform future care of individuals with narcolepsy